Patients Sue GLP-1 Drugmakers Over Risk of Sudden Vision Loss
Some countries have compelled Novo Nordisk and Eli Lilly to include warnings or information about NAION, a rare vision-loss condition, on their GLP-1 drug labels. There is no NAION warning on the drugs’ labels in the U.S., though the Food…